TAPAS TRIAL

Problem STEMI

Format Single-center, prospective, randomized, open trial involving the blinded evaluation of end points

Treatment Thrombus aspiration

Control Conventional PCI

Population 1071 patients

Inclusion criteria Symptoms suggesting acute myocardial ischemia lasting more than 30 minutes

The onset of symptoms less than 12 hours previously

ST-segment elevation of more than 0.1 mV in two or more leads on the ECG

Exclusion criteria Performance of a rescue PCI after thrombolysis

Known existence of a disease resulting in a life expectancy of less than 6 months

Lack of informed consent.

Follow-up 30 days

Primary endpoint Postprocedural frequency of a myocardial blush grade of 0 or 1

Secondary endpoint(s) Postprocedural frequencies of a Thrombolysis in Myocardial Infarction (TIMI) flow grade of 3

Complete resolution of ST-segment elevation

The absence of persistent ST-segment deviation

Rarget-vessel revascularization

Reinfarction

Death

Combination of major adverse cardiac events

Details -